GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Float Percentage Of Total Shares Outstanding

Zelira Therapeutics (ASX:ZLD) Float Percentage Of Total Shares Outstanding : 0.00% (As of Sep. 25, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zelira Therapeutics's float shares is 0.00 Mil. Zelira Therapeutics's total shares outstanding is 11.35 Mil. Zelira Therapeutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zelira Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zelira Therapeutics's Institutional Ownership is 0.03%.

Zelira Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Zelira Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/11.35
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelira Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:ANR ASX:AVE ASX:ILA ASX:BGT ASX:NYR ASX:NSB ASX:BTC ASX:PAB ASX:MEM ASX:IXC OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX
Traded in Other Exchanges
ZLDAF:USA G1G:Germany
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Website
https://www.zeliratx.com
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics Headlines

No Headlines